Toxicology Solutions Inc (TSI) is an independent consulting company focused on providing toxicology and DMPK services to the pharmaceutical industry.

With experienced scientists that, when combined, have over 50 years working in the industry, we can provide scientific and strategic consulting services. The provided range of services include nonclinical toxicology for the development of pharmaceutical drug candidates and specialty services in in silico toxicity predictions using 3 major predictive software programs (Leadscope Model Applier, DEREK Nexus, MultiCase) and GLP pharmacokinetic/toxicokinetic (PK/TK) reports (nonclinical and clinical). We have been providing the highest level of quality and exceptional service to our clients since 2012.

Key benefits provided by TSI:

Flexibility and Responsiveness
We understand the fast-paced nature of drug development and can provide expedited services, including ICH M7 evaluation of impurities and GLP PK/TK reports, as needed to best fit your timelines.

Breadth of Experience
Our scientists have worked on numerous INDs and NDAs spanning various therapeutic areas, routes of administration, and species and can provide guidance on regulatory expectations.

Professionalism and Integrity
TSI’s staff strive to operate with excellence in our work products and services and provide transparency to our clients on expectations and delivery of services.

"All things are poisons, for there is nothing without poisonous qualities. 
It is only the dose which makes a thing poison." — Paracelsus

Events

Please join us at the American College of Toxicology 45th annual meeting in Austin and come visit us at Booth 506!

News

Toxicology Solutions, Inc. has been providing toxicology consulting services since 2012, and Toxicology Solutions and ADME Solutions have been affiliated partners since the inception of ADME Solutions in 2016. The services both companies provide to our clients have been very complimentary, as toxicology and ADME are critical components of the nonclinical safety package, and they continue well beyond that space into clinical development. With the close working relationship between the companies, we have decided to officially merge them together into Toxicology Solutions, Inc., effective July 1, 2021.

We are excited with this strategic transition to allow our clients the ability to work with one company for their toxicology and DMPK services. We are committed to continue to provide our clients with the exceptional service and responsiveness they have come to appreciate when working with us. With this union, our clients will enjoy the same dedication and exemplary service they've come to expect from each of our companies.

Testimonials

Lisa (and Toxicology Solutions) are incredible.  The turnaround time was amazing.  The communication was impeccable.  And the reporting is better than any you'll find in this industry.  We will certainly be returning customers. 

Joel D. Moore, PhD
Senior Vice President Non-Clinical Development
Ropirio Therapeutics, Inc.

“Lisa, you’re amazing!! Thank you for the expedited response!”

John Limanto
Executive Director, Process Chemistry
Deerfield Discovery and Development
 

“Absolutely amazing service!  Thanks for turning this around so quickly.”

Sharon Hanegraaf
VP, Drug Development
Kinoxis Therapeutics Pty Ltd

“Thank you, Lisa. Appreciate the quick turnaround! It’s been a pleasure working with you.”

Son Nguyen
Sr. Director, Small Molecule Drug Substance Development and Manufacturing
PureTech Health